Hangzhou Jeci Biochemical Technology Co., Ltd. is a physical and chemical enterprise mainly based on pharmaceutical and chemical industry. The company has been established for a long time. It is located in Shangcheng District, a feng shui treasure land in Hangzhou, Zhejiang Province. It is beautiful and rich, with outstanding people, convenient transportation and economic development.
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Nanjing Peptide Research Biotech Co., Ltd.
As a professional R&D and manufacturing enterprise of peptide drugs, the company has a complete product portfolio of GLP-1 class drug APIs and their intermediates, with product quality complying with ICH, European Pharmacopoeia, and United States Pharmacopeia standards. It is one of the early domestic enterprises to lay out the industrial production of Ogliegron, equipped with mature solid-phase synthesis technology and stable scale-up production capacity. It can adapt to commercial orders of different scales and has earned an excellent reputation among domestic and international customers through high-purity products and timely technical support.
Shandong Chenxi Pharmaceutical Technology Co., Ltd.
Founded in 2018, the company focuses on the R&D and production of innovative drugs and high-end API intermediates, with product lines covering multiple high-demand therapeutic areas such as GLP-1 receptor agonists and anti-diabetic drugs. With a technical team of 200 to 300 people, it has accumulated rich experience in peptide synthesis and process optimization over the years, forming significant cost and technological advantages. It offers full-chain customized services from basic intermediates to complex APIs, catering to diverse needs including small-to-medium batch trial production and large-scale commercial procurement.
Hanrui Pharmaceutical (Jingmen) Co., Ltd.
As a wholly-owned subsidiary of Wuhan Hightec Biological Engineering Co., Ltd., its API+CDMO base is located in Jingmen, Hubei. It has GMP-compliant peptide production workshops and possesses the tonnage production capacity of Ogliegron intermediates. Leveraging the technical reserves of its parent company, the company has established a comprehensive quality control system, with product quality meeting international standards such as USP and EP. It provides integrated services from process development to commercial production for global pharmaceutical companies, making it one of the core CDMO partners in the GLP-1 track.
Shandong Tianming Pharmaceutical Group Co., Ltd.
The company focuses on the full industrial chain layout of GLP-1 class drugs and is one of the few domestic enterprises with the full-process production capacity of Ogliegron intermediates. Its independently developed synthesis process features high yield and stable purity, enabling scaled supply from kilogram to ton levels. Deeply partnering with global innovative pharmaceutical enterprises, it offers customized services such as process optimization and quality improvement. With efficient production capacity response and strict quality control, it has become a core supplier for global pharmaceutical companies tackling the GLP-1 track.
Hubei Weideli Chemical Technology Co., Ltd.
Located in Wuhan, Hubei, it is a high-end pharmaceutical raw material enterprise integrating R&D, production, and sales, focusing on the spot supply of research reagents and commercial APIs. The company has the synthesis capacity of Ogliegron and its intermediates, with product purity reaching over 99.5%, and exports to Europe, North America, Southeast Asia, and other countries and regions. With flexible small-batch customization capabilities and stable product quality, it has established a high reputation in the global peptide raw material market.
